Statera Biopharma Inc. Gains 62.84%
Thu, Oct 06, 2022 at 07:31 PM
Statera Biopharma Inc. (STAB:NASDAQ) shot up at $0.23, representing a gain of 62.8%. On Thu, Oct 06, 2022, STAB:NASDAQ touched a New 2-Week High of $0.23. From Thu, Sep 22, 2022, the stock recorded 30.00% Up Days and 18.18% Green Days
The stock spiked on Thu, Oct 06, 2022 at $0.3 with a volume of 82M+.
About Statera Biopharma Inc. (STAB:NASDAQ)
Statera BioPharma Inc is a clinical-stage biopharmaceutical company addressing autoimmune and inflammatory diseases, blood disorders, infectious diseases, and cancer.
Top 10 Gainers:
- Green Giant Inc Com (New) (GGE:NASDAQ), 161.11%
- Atlis Motor Vehicles Inc. (AMV:NASDAQ), 95.45%
- InVivo Therapeutics Holdings Corp. (NVIV:NASDAQ), 83.03%
- Pineapple Holdings Inc Com (PEGY:NASDAQ), 64.86%
- WM Technology Inc. (MAPS:NASDAQ), 64.29%
- Statera Biopharma Inc. (STAB:NASDAQ), 62.84%
- Code Chain New Continent Limited (CCNC:NASDAQ), 46.64%
- Kiromic BioPharma Inc. (KRBP:NASDAQ), 44.28%
- SpringBig Holdings Inc. (SBIG:NASDAQ), 44.21%
- Motus GI Holdings, Inc. (MOTS:NASDAQ), 38.3%